Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)
Clinical trial NCT02857946 · COMPLETED
Trial details
- NCT number
- NCT02857946
- Sponsor
- Genuine Research Center, Egypt
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2016-03-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.